Zimberelimab (Anti-PDCD1 / PD-1 / CD279)

Synonyms: GLS-010

Zimberelimab (Anti-PDCD1 / PD-1 / CD279) is a monoclonal antibody targeting programmed cell death protein 1 (anti-PD-1). It shows antitumor activities, and can be used for various cancers research, including cervical cancer, non-small cell lung cancer and classical Hodgkin’s lymphoma. MW :144.72 KD.

Zimberelimab (Anti-PDCD1 / PD-1 / CD279)

Purity & Quality Control

≥99

Choose Selective PD-1/PD-L1 Inhibitors

Biological Activity

Description Zimberelimab (Anti-PDCD1 / PD-1 / CD279) is a monoclonal antibody targeting programmed cell death protein 1 (anti-PD-1). It shows antitumor activities, and can be used for various cancers research, including cervical cancer, non-small cell lung cancer and classical Hodgkin’s lymphoma. MW :144.72 KD.

Product Details

CAS No. 2259860-24-5
Isotype Human IgG4SP
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Zimberelimab (Anti-PDCD1 / PD-1 / CD279) | Zimberelimab (Anti-PDCD1 / PD-1 / CD279) supplier | purchase Zimberelimab (Anti-PDCD1 / PD-1 / CD279) | Zimberelimab (Anti-PDCD1 / PD-1 / CD279) cost | Zimberelimab (Anti-PDCD1 / PD-1 / CD279) manufacturer | order Zimberelimab (Anti-PDCD1 / PD-1 / CD279) | Zimberelimab (Anti-PDCD1 / PD-1 / CD279) distributor